AHL Partners’s MiMedx Group MDXG Stock Holding History

AHL Partners’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-162,282	Closed	-$1.93M	–	1314
2017 Q3	$1.93M	Buy	+162,282	New	+$2.41M	0.03%	681

Other funds holding MDXG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

AHL Partners's MDXG Position: Q4 2017 in Review

AHL Partners sold out of MiMedx Group (MDXG) in Q4 2017, closing a stake of 162,282 shares — an estimated $1.93M sold.

AHL Partners first reported a position in MDXG in Q3 2017 and held it in 1 quarter. The position peaked at $1.93M in Q3 2017. 236 funds tracked by Wall St. Rank hold MDXG as of Q4 2017.

AHL Partners reported no remaining MiMedx Group position as of Q4 2017 after selling out during the quarter.
AHL Partners sold 162,282 MiMedx Group shares in Q4 2017, an estimated $1.93M.
AHL Partners first reported a position in MiMedx Group in Q3 2017 and held it in 1 quarter.
AHL Partners's MiMedx Group position peaked at $1.93M in Q3 2017.
236 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.